Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-23
DOI
10.1038/s41419-020-03076-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity
- (2019) Tsang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model
- (2018) Ailing Sui et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
- (2018) Shyam S. Chaurasia et al. Scientific Reports
- ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis
- (2018) Ailing Sui et al. MEDICAL SCIENCE MONITOR
- Neutralization of IL-23 depresses experimental ocular neovascularization
- (2016) Yujuan Cai et al. EXPERIMENTAL EYE RESEARCH
- Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization
- (2016) Yanji Zhu et al. IMMUNOLOGY
- Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy
- (2016) Angèle Nalbandian et al. INFLAMMATION
- Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation
- (2016) Michael J. Primiano et al. JOURNAL OF IMMUNOLOGY
- An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
- (2016) Isis Ludwig-Portugall et al. KIDNEY INTERNATIONAL
- Knockout of Ccr2 alleviates photoreceptor cell death in rodent retina exposed to chronic blue light
- (2016) Zizhong Hu et al. Cell Death & Disease
- Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells
- (2016) Beth Coughlin et al. Scientific Reports
- Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina
- (2015) Yi Qiu et al. ACTA DIABETOLOGICA
- Inflammasome-Independent Regulation of IL-1-Family Cytokines
- (2015) Mihai G. Netea et al. Annual Review of Immunology
- Angiopoietin 2 Induces Pericyte Apoptosis via 3 1 Integrin Signaling in Diabetic Retinopathy
- (2014) S. W. Park et al. DIABETES
- IL-18 Attenuates Experimental Choroidal Neovascularization as a Potential Therapy for Wet Age-Related Macular Degeneration
- (2014) S. L. Doyle et al. Science Translational Medicine
- Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus
- (2014) J-Y Liu et al. Cell Death & Disease
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions
- (2013) Ingeborg Klaassen et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Signal Transduction by Vascular Endothelial Growth Factor Receptors
- (2013) S. Koch et al. Cold Spring Harbor Perspectives in Medicine
- Neuropeptides and diabetic retinopathy
- (2012) Robert Gábriel BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components
- (2012) Sarah L Doyle et al. NATURE MEDICINE
- Ocular Complications After Anti–Vascular Endothelial Growth Factor Therapy in Medicare Patients With Age-Related Macular Degeneration
- (2011) Shelley Day et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
- (2011) Michael Tolentino SURVEY OF OPHTHALMOLOGY
- Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor Action
- (2010) Napoleone Ferrara MOLECULAR BIOLOGY OF THE CELL
- Meprin A and meprin α generate biologically functional IL-1β from pro-IL-1β
- (2009) Christian Herzog et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prointerleukin-18 Is Activated by Meprin βin Vitroandin Vivoin Intestinal Inflammation
- (2008) Sanjita Banerjee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More